Immunotherapy by Nivolumab for HIV+ Patients

Clinical trial NCT03304093 · COMPLETED

Trial details

NCT number: NCT03304093
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Stage IIIB HIV/AIDS

Start date: 2017-10-19
Primary completion: 2021-02-18
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.